NYSE · Health Care · Drug Manufacturers - General
PFE
Pfizer Inc.
Develops prescription drugs and vaccines, pivoting toward oncology after buying Seagen as its COVID-19 revenue receded.
$26.79-0.04%
Close · 2026-08-14$22$24$26
NovFebMayAug
$22.03
$27.8052-week range, last close at 83% of the range
- 1W
- +0.11%
- 1M
- +9.83%
- 3M
- +7.61%
- 6M
- +0.47%
- YTD
- +13.14%
- 1Y
- +14.17%
- Avg vol 20d
- 39.3M
- RVOL
- 0.47
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $152.69B
- P/E
- 35.3
- Fwd P/E
- 9.3
- EPS
- $0.76
- Div yield
- 6.42%
- Beta
- 0.28
- Employees
- 75K
- Next earnings
- 2026-11-03
Rating & verdict historyoldest → newest
100.0% correct+1.08% avg moveBUY 1/1 · HOLD 0/0 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |